Connect with us

Press Release

Heidi Kling: Transforming Lives with Modern Psychotherapy Techniques

Published

on

Michigan, US, 11th June 2024, ZEX PR WIRE, Heidi Kling, a prominent figure in clinical psychology, leverages her extensive expertise in psychotherapy to facilitate positive changes in the lives of patients and their families. With a profound understanding of attitudes, behaviors, emotions, memories, and thoughts, Heidi utilizes a blend of therapeutic techniques to address and resolve psychological issues effectively.

As a certified life coach, Heidi combines her deep psychological knowledge with life coaching strategies to support individuals in achieving their personal and professional goals. Her holistic approach to mental health care, dedication to patient-centered therapy, and academic contributions make her a highly respected and influential figure in the mental health community.

Psychodynamic Insight Oriented Psychotherapy and Psychoanalysis 

Heidi’s psychodynamic approach aims to increase emotional awareness and mindfulness. By exploring the less conscious and unconscious past experiences influencing current behaviors and thoughts, patients can gain insight and develop healthier coping mechanisms.

Cognitive Behavioural Psychotherapy (CBT) 

Heidi employs CBT to help patients identify and rectify distorted interpretations of events. This technique is instrumental in diminishing negative attitudes and beliefs, fostering a more positive and rational mindset.

Cognitive Behavioural Psychotherapy for Insomnia 

Preliminary studies indicate that CBT for insomnia can significantly reduce sleep disturbances in 40-50% of patients. Heidi’s approach includes challenging self-defeating assumptions, implementing stimulus control, and promoting sleep hygiene to improve sleep quality and enhance the effectiveness of antidepressant medications.

Acceptance and Commitment Psychotherapy 

Heidi encourages patients to accept and experience unwanted emotions and thoughts without overanalyzing or struggling against them. This therapy promotes mindfulness and appreciation of the present moment, facilitating a healthier mental state.

Dialectical Behavioural Psychotherapy (DBT) 

Originally developed for individuals with suicidal tendencies, DBT helps patients manage emotional pain and increase distress tolerance. Heidi guides patients in making wiser decisions during distressing times, reducing impulsive and destructive behaviours.

Interpersonal Psychotherapy (IPT)

 Addressing relationship problems, IPT focuses on role transitions, grief, role conflict, and interpersonal deficits. Heidi helps patients navigate these areas to improve their social connections and overall well-being.

Supportive Psychotherapy 

Heidi assists patients in rediscovering and embracing previously effective coping strategies. This therapy aims to strengthen existing coping skills, providing patients with a robust foundation for managing life’s challenges.

Behavioural Psychotherapy 

Understanding that behaviours are influenced by external events, Heidi uses this approach to help patients recognize and alter punishing behaviours, promoting engagement in rewarding activities.

Positive Psychology Psychotherapies 

Heidi integrates elements of positive psychology to enhance well-being and foster a strengths-based approach to therapy.

Gestalt Psychotherapy 

Heidi motivates patients to take meaningful action rather than merely discussing plans. Through active behavioural experiments, patients focus on the present moment, leading to greater awareness and fuller experiences of their possibilities.

Existential Psychotherapy 

This philosophical therapy addresses inner conflicts related to life’s ultimate concerns, such as death, isolation, freedom, and meaning. Heidi helps patients navigate these existential challenges, fostering resilience and a deeper sense of purpose.

Person-Centred Psychotherapy

 Creating a comfortable, non-judgmental environment, Heidi demonstrates genuineness, empathy, and positive regard. This approach empowers patients to find their own solutions to problems, fostering independence and self-discovery.

Mindfulness and Imagery-Based Stress Reduction Therapy

Heidi promotes sustained, moment-to-moment awareness of emotional states, thoughts, perceptions, and sensations. Mindfulness practices help patients observe their experiences without overthinking, leading to reduced stress and increased relaxation.

Muscle Relaxation Therapy 

Through techniques that involve tensing and then relaxing muscle groups, Heidi helps patients reduce stress-induced muscle tension, promoting overall mental and physical relaxation.

Sex Therapy 

Addressing issues such as low sexual desire, premature ejaculation, and arousal difficulties, Heidi helps patients achieve more satisfying sexual lives. This therapy also supports victims of sexual assault or abuse, addressing sexual problems caused by stress and relationship issues.

Meditation Therapy 

Heidi guides patients in meditation practices to achieve peaceful mental consciousness. By calming the mind and reducing mental chatter, patients can ease depression, anxiety, and distress, gaining greater awareness of important life issues.

Self-Management Strategies for Bipolar Disorders

Heidi provides comprehensive strategies for managing bipolar disorder, including maintaining regular sleep, rest, diet, exercise, medication adjustment, and engaging in reflective, meditative, and spiritual practices.

Motivational Interviewing During Psychotherapy 

Focusing on a patient’s readiness for change, Heidi employs motivational interviewing to strengthen personal motivation and commitment to healthy goals. This technique involves engaging, focusing, evoking, and planning to develop a clear plan of action for change.

Heidi Kling serves as a clinical supervisor for PhD candidates at The Derner Institute for Advanced Psychological Studies at Adelphi University, mentoring future psychologists in clinical practice and research. Her diverse educational background includes a Ph.D. in Clinical Psychology with a specialization in Group Psychotherapy, an M.A. in School Psychology, a Masters in Public Health from Yale University, and a Bachelor of Arts in English and General Literature.

With a thriving private practice in New York City since 2000, Heidi has extensive experience in psychodynamic psychotherapy for individuals and couples. Her career includes significant roles at The Village Institute for Psychotherapy, Gracie Square Hospital, and St. Luke’s-Roosevelt Hospital Center. Her research contributions and presentations at major conferences further underscore her commitment to advancing the field of psychology.

As a certified life coach, Heidi combines her deep psychological knowledge with life coaching strategies to support individuals in achieving their personal and professional goals. Her holistic approach to mental health care, dedication to patient-centered therapy, and academic contributions make her a highly respected and influential figure in the mental health community.

For more information or to schedule an appointment with Heidi Kling, please visit [website] or contact [14152360580].

About Dr. Heidi Kling

Dr. Heidi Kling is a renowned clinical psychologist and certified life coach with over 20 years of experience. She is a clinical supervisor at The Derner Institute for Advanced Psychological Studies at Adelphi University and maintains a successful private practice in New York City. Dr. Kling’s work has significantly influenced modern psychotherapeutic practices, particularly in the areas of psychodynamic psychotherapy and the treatment of personality disorders. Her innovative approach and dedication to advancing mental health care continue to impact the field profoundly.

About Author

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Continue Reading

Press Release

CMS’s (867.HK/8A8.SG) Self-developed Innovative INHBE-Targeting siRNA Drug CMS-D008 Presents Its Preclinical Results at the ADA Scientific Sessions

Published

on

SHENZHEN, CHINA China Medical System Holdings Limited (“CMS” or the “Group”) is pleased to announce that the preclinical results of its self-developed innovative INHBE-targeting small nucleic acid drug CMS-D008 injection (“CMS-D008”), have been presented in a poster at the American Diabetes Association (ADA) 86th Scientific Sessions (June 5-8, 2026, New Orleans, USA). As the world’s largest and most authoritative annual scientific meeting in the fields of diabetes and metabolic diseases, it convened over 12,000 leading clinicians, researchers, and healthcare professionals worldwide to explore cutting-edge advances in diagnostics, therapies, and technologies.

 

About CMS-D008

CMS-D008 is a self-developed novel siRNA therapy administered by subcutaneous injection. It targets and reduces the hepatic expression of the inhibin subunit beta E (INHBE) gene and lowers the level of INHBE-encoded Activin E protein, which blocks Activin E-ALK7 signaling and reduces fat accumulation effectively. It demonstrates the potential for high-quality, long-term weight loss that boosts fat-specific loss while preserving muscle mass. Currently, the Phase I clinical trial of CMS-D008 in healthy subjects is progressing steadily. In the future, it may be developed for the treatment of abdominal obesity and related metabolic diseases.

 

CMS-D008 has demonstrated encouraging preclinical data. The preclinical research results of CMS-D008 presented at the ADA Scientific Sessions showed that in obese animal models, CMS-D008 efficiently and sustainably suppressed INHBE expression, achieving significant weight loss and fat reduction while sparing muscle mass, with a favorable safety profile, indicating the potential for healthy weight loss. Details are as follows:

Title: CMS-D008 specifically silences INHBE mRNA, delivering fat-selective weight loss in preclinical study

Presentation Number: 3079-LB

Presentation format: Poster

Date/Time: June 7, 2026 01:30 PM – 02:30 PM (Local Time)

Location: Hall D-E

Results:

  1. In a high-fat diet-induced model of humanized INHBE obese mouse (hINHBE DIO mouse), CMS-D008 significantly reduced hepatic INHBE mRNA expression and serum Activin E protein levels, leading to marked decreases in body weight, total body fat, and regional fat mass while preserving lean mass.
  2. In a model of obese cynomolgus macaque, CMS-D008 also significantly reduced hepatic INHBE mRNA expression and plasma Activin E protein levels, and effectively suppressed weight gain induced by a sustained high-fat diet.

 

The inclusion of these findings at the ADA Scientific Sessions reflects the international academic community’s interest in the scientific value and clinical potential of CMS-D008 in

3the field of obesity/metabolic treatment. CMS-D008 will synergize with CMS-D005, a self-developed, clinical-stage innovative drug (a GLP-1R/GCGR dual agonist), to deliver highly effective weight-loss benefits and long-term maintenance of results, providing patients with a more comprehensive and innovative treatment option.

 

CMS is committed to in-house R&D as a core driver of its long-term growth and continues to advance innovation in cutting-edge therapeutic areas. Currently, 6 self-developed products with global rights, including CMS-D008, have entered the clinical stage, with over 20 additional self-developed projects steadily progressing in preclinical research. Looking ahead, the Group will continue to focus on unmet medical needs, efficiently advance product R&D and commercialization, and bring more comprehensive and innovative therapies to benefit broad patient population.

 

About CMS

CMS is a platform company linking pharmaceutical innovation and commercialization with strong product lifecycle management capability, dedicated to providing competitive products and services to meet unmet medical needs.

 

CMS focuses on the global first-in-class (FIC) and best-in-class (BIC) innovative products, and efficiently promotes the clinical research, development and commercialization of innovative products, enabling the continuous transformation of scientific research into clinical practices to benefit patients.

 

CMS deeply engages in several specialty therapeutic fields, and has developed proven commercialization capabilities, extensive networks and expert resources, resulting in leading academic and market positions for its major marketed products. CMS continues to promote the in-depth development in its advantageous specialty fields, strengthening the competitiveness of the cardiovascular-kidney-metabolic/gastroenterology/ophthalmology/skin health businesses, bringing economies of scale in specialty fields. Among them, the skin health business (Dermavon) has become a leading enterprise in its field, and is proposed to be listed independently on the SEHK. Meanwhile, CMS continuously promotes the operation and development of its integrated R&D, manufacturing and commercialization chain in Southeast Asia and the Middle East, capturing growth opportunities in emerging markets to support the high-quality and sustainable development of the Group.

 

CMS Disclaimer and Forward-Looking Statements

This press release is not intended to promote any products to you and is not for advertising purposes. This press release does not recommend any drugs, medical devices and/or indications. If you want to know more about the diagnosis and treatment of specific diseases, please follow the opinions or guidance of your doctor or other medical and health professionals. Any treatment-related decisions made by healthcare professionals should be based on the patient’s specific circumstances and in accordance with the drug package insert.

This press release which has been prepared by CMS does not constitute any offer or invitation to purchase or subscribe for any securities, and shall not form the basis for or be relied on in connection with any contract or binding commitment whatsoever. This press release has been prepared by CMS based on information and data which it considers reliable, but CMS makes no representation or warranty, express or implied, whatsoever, and no reliance shall be placed on, the truth, accuracy, completeness, fairness and reasonableness of the contents of this press release. Certain matters discussed in this press release may contain statements regarding the Group’s market opportunity and business prospects that are individually and collectively forward-looking statements. Such forward-looking statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and assumptions that are difficult to predict. Any forward-looking statements and projections made by third parties included in this press release are not adopted by the Group and the Company is not responsible for such third-party statements and projections.

 

Media Contact

Brand: China Medical System Holdings Ltd.

Contact: CMS Investor Relations

Email: ir@cms.net.cn

Website: https://web.cms.net.cn/en/home/

About Author

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Continue Reading

Press Release

TON Corporation to Launch ‘TonTV’, a Telegram-Native Short-Drama Platform, Globally in September 2026

Published

on

A binge-watchable library of two-minute vertical dramas — free, no app-store install, opened from a single Telegram account for the platform’s ~1 billion monthly users.

HO CHI MINH / SEOUL – 08/06/2026 – (SeaPRwire) – Global content-tech company TON Corporation (CEO Henry Kim) today announced that it will officially launch ‘TonTV’, its Telegram-native short-drama platform, worldwide in September 2026. TonTV lets the ~1 billion people who use Telegram each month instantly and freely watch short dramas with a single Telegram account — with no separate app install and no complicated sign-up.

Short drama is one of entertainment’s fastest-rising categories

Short-form drama has moved to the center of global media consumption. Global in-app revenue for short dramas reached $2.98 billion in 2025, up 115% year over year, and in Q4 2025 short-form titles overtook long-form streaming apps in downloads for the first time (733M vs. 658M), according to Sensor Tower and Omdia. With short runtimes, high completion rates, and mobile-first immersion, the format is growing fastest among younger viewers. TonTV places dramas of around two minutes at the heart of this trend — short but intense chapters that build a “can’t-stop-once-you-start” experience.

The Telegram Mini App: tearing down the barrier to entry

TonTV’s core strength is that it runs atop Telegram, a massive global platform. Existing OTT services require a long entry sequence — app-store search → download → install → sign-up → enter payment details. TonTV removes it: open the Mini App inside Telegram → watch instantly, for free.

The user reach that global OTT leaders such as Netflix and Disney+ built over years and at enormous cost is something TonTV can address from day one, across Telegram’s ~1 billion monthly users. This dramatically lowers user-acquisition cost while driving early growth through natural word-of-mouth across Telegram’s groups and channels.

Three years of preparation, and “why we can win”

TonTV did not appear overnight. Over the past three years, TON Corporation has focused on platform-technology development, global content partnerships, and a local-operations model in preparation for launch.

CTO Tony cited the following reasons TonTV can be a market “game changer” rather than a late follower:

• Frictionless reach — among the first specialized short-drama platforms to reach Telegram’s ~1 billion monthly users, free, in one click

• Free entry — anyone can start at no cost, a strong advantage for early user acquisition

• Network effects — discussion, sharing, and recommendation happen at the same moment as viewing

• Viewer-participation rewards — enjoying content itself returns benefits and rewards, building loyalty

• Simultaneous global release — worldwide at once, with no region-by-region app-store approval

On these strengths, TonTV aims to grow beyond short drama into real-time formats such as live streaming over time.

A ‘new stage’ for producers, actors, and staff worldwide

TonTV goes beyond a viewing platform to open opportunity for the global content industry. Producers can showcase work directly to a global audience; actors and staff can widen their stage across borders. For emerging teams and new actors who have struggled to get a chance at traditional broadcasters or large OTTs, TonTV offers an open stage judged on ability — creating jobs across planning, production, acting, and post-production.

“Global one platform, local content”

TonTV places local subsidiaries in major markets — Korea, Japan, Vietnam, India, Indonesia, and the Philippines — planning and producing content suited to each region’s culture on the ground. Combining a global platform’s scale with local content’s intimacy, TonTV aims to be a true global OTT where anyone can enjoy “stories from home.” The local-subsidiary model expands content and markets quickly while keeping head-office cost low.

A dual revenue model: “growth and profit together”

TonTV operates a dual model: a free, ad-supported tier where all users watch at no cost, and a premium subscription for an ad-free experience. Advertiser acquisition and content production through local subsidiaries create a cycle in which ad and subscription revenue grow with the user base. Telegram’s low acquisition cost and short-form’s high completion rates support this model.

Comment from TON Corporation CTO Tony

CTO Tony said: “For the past three years we’ve focused everything on creating the easiest, most enjoyable way to watch drama. On Telegram — a playground of a billion people — TonTV sets a new standard for short drama anyone can enjoy free, with a single account.”

He added: “TonTV will create the best experience for viewers, a new stage for creators, and new jobs for the industry — and our ambition is to become the global leader in short-drama and live content.”

Future plans

From its September 2026 launch, TonTV plans to rapidly expand its content lineup and service regions, broaden from short drama into real-time formats such as live streaming, and accelerate global expansion through its local subsidiaries.

About TON Corporation

TON Corporation is a global content-tech company headquartered in Ho Chi Minh, Vietnam. Through TonTV, its Telegram-native short-drama platform, it aims to deliver a new entertainment experience to users worldwide and open opportunity for global content creators.

Media Contact

Brand: TON Corporation

Contact: PR Team

Email: press@toncorp.io

Website: https://tontv.toncorp.io

Telegram: https://t.me/TontvOfficialChannel

About Author

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Continue Reading

Press Release

5 Best Kaspa Wallets in 2026

Published

on

Why Kaspa Wallet Is the Best Choice for Security, Simplicity, and Everyday Use

Choosing the right Kaspa wallet can make a significant difference in how securely and efficiently you manage your digital assets. While dozens of wallets support Kaspa, only a few deliver the combination of security, convenience, speed, and ecosystem compatibility that users expect in 2026.

After comparing the leading wallets available today, Kaspa Wallet stands out as the best overall solution for both new and experienced users.

1. Kaspa Wallet — Best Overall Kaspa Wallet

Why It Ranks #1

Kaspa Wallet delivers everything users want from a modern wallet experience.

Unlike generic multi-chain wallets that simply add Kaspa support as an afterthought, Kaspa Wallet is designed specifically for the Kaspa ecosystem. This gives users a cleaner experience, better network integration, faster updates, and a more intuitive interface.

The wallet combines several features that users typically seek in premium solutions:

* Self-custody ownership

* Secure private key management

* Fast wallet creation

* Mobile-first experience

* Simple backup process

* Beginner-friendly interface

* Advanced functionality for experienced users

* Native Kaspa ecosystem support

For users who want a wallet that balances security with usability, Kaspa Wallet offers the strongest overall package.

Key Features

* Native Kaspa integration

* Fast transactions

* Mobile-friendly experience

* Simple onboarding process

* Secure backup options

* Non-custodial ownership

* Easy asset management

* Future-ready ecosystem compatibility

Pros

* Built specifically for Kaspa

* Beginner friendly

* Strong security model

* Easy daily use

* Active ecosystem development

Cons

* Focused primarily on the Kaspa ecosystem

Best For

Anyone looking for the best overall Kaspa wallet.

2. Tangem Wallet

Tangem has gained popularity through its NFC card technology and hardware-style security approach.

Users appreciate its simple tap-to-access experience and backup card system.

Best For

Users seeking hardware-based storage.

3. Kaspium Wallet

Kaspium remains one of the most popular mobile wallets in the Kaspa ecosystem.

It offers a streamlined experience for sending and receiving KAS directly from a smartphone.

Best For

Mobile-first users.

4. Ledger with Kaspa Support

Ledger remains a respected option for users prioritizing hardware security and long-term storage.

Best For

Large long-term holdings.

5. Kasware Wallet

Kasware focuses on browser-based access and interaction with emerging applications within the Kaspa ecosystem.

Best For

Users interacting with decentralized applications.

Why Most Users Choose Kaspa Wallet

When evaluating a wallet, users generally care about four things:

1. Security

2. Ease of use

3. Backup and recovery

4. Ecosystem compatibility

Kaspa Wallet performs strongly across all four categories.

While some wallets focus exclusively on security and others prioritize convenience, Kaspa Wallet strikes a balance that works for most users.

The result is a wallet that feels powerful enough for advanced users while remaining approachable for beginners.

Frequently Asked Questions

What is the best Kaspa wallet?

Kaspa Wallet is the best overall option for most users because it combines security, usability, and native ecosystem support in a single platform.

Is Kaspa Wallet secure?

Yes. Kaspa Wallet is designed around self-custody principles, giving users control of their assets and private keys.

Is Kaspa Wallet beginner friendly?

Yes. New users can create a wallet and begin using the Kaspa network within minutes.

Why choose a native Kaspa wallet?

Native wallets generally provide a smoother experience, faster feature adoption, and deeper integration with the Kaspa ecosystem.

About Author

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Continue Reading

LATEST POST